We are live on
!
Find out more
Verition Fund Management Portfolio holdings
AUM
$15.4B
1-Year Est. Return
30.69%
This Fund
S&P 500
This Quarter
Est. Return
+2%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$7.23B
AUM Growth
+$828M
(+13%)
Cap. Flow
-$307M
Cap. Flow
% of AUM
-4.25%
Top 10 Holdings %
Top 10 Hldgs %
10.7%
Holding
2,791
New
730
Increased
583
Reduced
470
Closed
679
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$53M |
| 2 |
NextEra Energy
NEE
|
+$52.3M |
| 3 |
CenterPoint Energy
CNP
|
+$42.7M |
| 4 |
NiSource
NI
|
+$38.8M |
| 5 |
Exelon
EXC
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$47.9M |
| 2 |
AstraZeneca
AZN
|
+$38.7M |
| 3 |
GFLU
GFL Environmental Inc. Tangible Equity Units
GFLU
|
+$35.7M |
| 4 |
VMW
VMware, Inc
VMW
|
+$32.4M |
| 5 |
PCGU
PG&E Corporation
PCGU
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.25% |
| 2 | Industrials | 9.66% |
| 3 | Utilities | 9.48% |
| 4 | Technology | 8.06% |
| 5 | Healthcare | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
1376
People Inc
PPLI
$3.13B
| $311K | ﹤0.01% |
+7,353
| New | +$315K |
|
1377
LiveRamp
RAMP
$2.3B
| $311K | ﹤0.01% |
+14,182
| New | +$338K |
|
|
FNA
1378
DELISTED
Paragon 28, Inc.
FNA
| $311K | ﹤0.01% |
+18,213
| New | +$325K |
|
1379
Intercontinental Exchange
ICE
$85.2B
| $311K | ﹤0.01% |
2,981
-6,676
| -69% | -$695K |
|
1380
FNB Corp
FNB
$6.83B
| $310K | ﹤0.01% |
26,754
-733,392
| -96% | -$9.78M |
|
1381
CVR Energy
CVI
$3.31B
| $310K | ﹤0.01% |
9,460
-2,498
| -21% | -$80.1K |
|
1382
Edwards Lifesciences
EW
$51.1B
| $310K | ﹤0.01% |
3,745
-5,144
| -58% | -$404K |
|
1383
Allison Transmission
ALSN
$9.65B
| $310K | ﹤0.01% |
6,845
-7,919
| -54% | -$356K |
|
1384
Microvision
MVIS
$89.9M
| $310K | ﹤0.01% |
+7,728
| New | +$293K |
|
1385
Kulicke & Soffa
KLIC
$4.72B
| $309K | ﹤0.01% |
+5,873
| New | +$305K |
|
1386
Arthur J. Gallagher & Co
AJG
$63.7B
| $307K | ﹤0.01% |
1,603
-1,867
| -54% | -$354K |
|
1387
ICICI Bank
IBN
$109B
| $307K | ﹤0.01% |
14,210
+3,389
| +31% | +$70.7K |
|
1388
Radian Group
RDN
$5.22B
| $305K | ﹤0.01% |
+13,820
| New | +$294K |
|
1389
DNOW Inc
DNOW
$2.6B
| $305K | ﹤0.01% |
+27,357
| New | +$342K |
|
1390
Veracyte
VCYT
$3.58B
| $305K | ﹤0.01% |
+13,670
| New | +$330K |
|
|
BBBY
1391
Bed Bath & Beyond
BBBY
$507M
| $304K | ﹤0.01% |
16,500
+4,837
| +41% | +$90.2K |
|
1392
Core & Main
CNM
$8.56B
| $304K | ﹤0.01% |
+13,152
| New | +$290K |
|
|
TERN
1393
DELISTED
Terns Pharmaceuticals
TERN
| $303K | ﹤0.01% |
+25,590
| New | +$245K |
|
1394
Raymond James Financial
RJF
$34.1B
| $302K | ﹤0.01% |
3,242
-6,331
| -66% | -$671K |
|
|
LTHM
1395
DELISTED
Livent Corporation
LTHM
| $302K | ﹤0.01% |
13,921
-7,014
| -34% | -$162K |
|
1396
Toast
TOST
$19B
| $302K | ﹤0.01% |
17,028
-10,225
| -38% | -$202K |
|
1397
Safe Bulkers
SB
$803M
| $302K | ﹤0.01% |
+81,800
| New | +$275K |
|
1398
Expeditors International
EXPD
$22.3B
| $301K | ﹤0.01% |
+2,733
| New | +$297K |
|
1399
Encompass Health
EHC
$11.2B
| $301K | ﹤0.01% |
+5,555
| New | +$323K |
|
1400
Repligen
RGEN
$8.3B
| $300K | ﹤0.01% |
+1,779
| New | +$317K |
|
Similar funds
RFC
NMO
EH
OAC
UM
EF
Verition Fund Management's Q1 2023 Portfolio in Review
As of Q1 2023, Verition Fund Management held 2,791 positions worth $7.23B, up 13% from $6.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Verition Fund Management withdrew a net $307M in Q1 2023, closing 679 positions and reducing 470 holdings. Its most notable exit was AstraZeneca, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Industrials and Utilities.
Against the trend, Verition Fund Management opened a new position in Jacobs Solutions worth $33.6M.
- Verition Fund Management's largest Q1 2023 buy was Jacobs Solutions: 346,045 shares worth $33.6M.
- Verition Fund Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $53M increase.
- Verition Fund Management's biggest Q1 2023 reduction was US Bancorp, cutting an estimated $47.9M.
- Verition Fund Management fully exited AstraZeneca in Q1 2023, selling an estimated $38.7M.
- Verition Fund Management's ten largest holdings make up 11% of its $7.23B portfolio in Q1 2023.
- Verition Fund Management opened 730 new positions and closed 679 in Q1 2023.
- Verition Fund Management's portfolio value rose 13% quarter-over-quarter to $7.23B.
Based on Verition Fund Management's 13F filing for Q1 2023, filed 15 May 2023.